Embedded Files
MJFF LITE Study
MJFF LITE Study
The MJFF LRRK2 Investigative Therapeutics Exchange
(LITE) program: A new study towards developing
quantifiable biomarkers for Parkinson’s disease
UK clinical studies update_LRRK2_LITE.pdfRecruiting Locations:
Kuala Lumpur, Malaysia
Taipei, Taiwan
Vienna, Austria
Sevilla, Spain
Dundee, UK
US PPMI (IND & USCF)
Barcelona, Spain
San Sebastian, Spain
Lübeck, Germany
Timeframe: This study is scheduled to open in Spring 2025
Recruitment Target: 150 in the UK (1000 worldwide)
Further Information
Further Information
The MJFF LRRK2 Investigative Therapeutics Exchange (LITE) Study: The LITE Study is an observational, multi-center cross-sectional international study with the additional option for follow up.
Aims: to discover and test new biological markers for LRRK2-driven Parkinson’s disease (PD) in various genetic (monogenic) PD and non-genetic (idiopathic) PD populations, people at risk for PD, and healthy controls and correlate these with clinical and imaging features of disease state and progression.
Global / UK study lead: Esther Sammler
UK study coordinator : Tiffany Stewart
Recruitment target: 1000 (global), up to 150 (UK)
Interested Investigators:
Interested Investigators:
To discuss this study further, contact our coordinator Emma Fargher md4efa@sheffield.ac.uk
People with Parkinson's:
People with Parkinson's:
Please visit the Michael J. Fox Foundation website to learn more about the study: website
Page updated
Report abuse